Presentation NY Valves 2024 Impact of Optimal Procedural Result After Transcatheter Edge‐to‐Edge Tricuspid Valve Repair: The Transcatheter Tricuspid Valve Repair in Spain (TRI-SPA) Registry Presenter: Julio Cesar Echarte Morales June 06, 2024
Presentation NY Valves 2024 RAVR or TAVR as an Interventional Cardiologist – My Clinical Decision Making Presenter: Ramesh Daggubati June 06, 2024
Presentation NY Valves 2024 Heterotopic TTVR in Patients With Severe TR: First-in-Human Experience With the Trillium Device Presenter: Philipp Lurz June 06, 2024
Presentation NY Valves 2024 Debate Pro: Invasive Assessment is Mandatory to Confirm Bioprosthetic Valve Dysfunction /Failure Presenter: David A. Wood June 06, 2024
Presentation NY Valves 2024 CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough Presenter: Michael Joseph Rinaldi June 06, 2024
Presentation NY Valves 2024 Con: Echocardiography Is Outdated –CMR Is the New Standard! Presenter: Joao L. Cavalcante June 06, 2024
Presentation NY Valves 2024 Expanding Indications for LAAO to Front Line Therapy for Stroke Reduction in AF: Clinical Trial Updates Presenter: Shephal K. Doshi June 06, 2024
Presentation NY Valves 2024 PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear Presenter: JoAnn Lindenfeld June 06, 2024
Presentation NY Valves 2024 Pro: Echocardiographic Assessment Is Still the "Gold Standard" for AR Presenter: Aarti Patil June 06, 2024
Presentation NY Valves 2024 Residual Tricuspid Regurgitation After Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights Into the Eurotr Registry Presenter: Lukas Stolz June 06, 2024